Live Breaking News & Updates on Canadian Stock Exchange Agn Cn

Stay updated with breaking news from Canadian stock exchange agn cn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Algernon NeuroScience and the Centre for Human Drug

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:. ....

Noord Holland , United Kingdom , British Columbia , Christopherj Moreau , Rick Strassman , Algernon Pharmaceuticals Inc , Constraint Induced Movement Therapy , Algernon Pharmaceuticals , Centre For Human Drug Research , Seyltx Inc , Interdisciplinary Conference On Psychedelic Research , Company Phase , Algernon Neuroscience , Human Drug Research , Interdisciplinary Conference , Psychedelic Research , Katelijne Van , Spirit Molecule , Brain Derived Neurotrophic Factor , Constraint Induced Movement , Stroke Study , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals Inc , Phase 1 , Algernon Neuroscience ,

Algernon Pharmaceuticals Announces 4 for 1 Forward Share

VANCOUVER, British Columbia, Feb. 28, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or. ....

United Kingdom , British Columbia , Christopherj Moreau , Trust Company , Algernon Pharmaceuticals , Company Or Algernon , Algernon Pharmaceuticals Inc , Shareholders Of The Company Do , Common Shares , Common Share , Forward Split , Algernon Neuroscience , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals ,

Algernon Pharmaceuticals Announces Plans for a 180 Patient

Ifenprodil Represents a Novel First-in-Class Potential Treatment for Chronic Cough. ....

United States , United Kingdom , British Columbia , Christopherj Moreau , Jacky Smith , Company Phase , Honorary Consultant At Manchester University , Algernon Pharmaceuticals , University Of Manchester , Drug Administration , Merck Co , Algernon Pharmaceuticals Inc , Afferent Pharmaceuticals , Bellus Health , While The Company , Market Research , Respiratory Medicine , Honorary Consultant , Manchester University , Idiopathic Pulmonary Fibrosis , Investigational New Drug , Data Bridge Market Research , Algernon Neuroscience , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals ,

Algernon Pharmaceuticals Enters into a Clinical Trial

VANCOUVER, British Columbia, Oct. 24, 2022 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0). ....

United States , United Kingdom , Yale School , British Columbia , Christopherj Moreau , Deepak Cyril Dsouza , Deepak Dsouza , Yale University , Yale School Of Medicine , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Yale University School Of Medicine , Company Or Algernon , Schizophrenia Neuropharmacology Research Group , Investigator Initiated Clinical Trial Agreement , Professor Deepak Cyrild Souza , United States Government , Deepakd Souza , Yale University School , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals , Phase 2 , Linical Triial ,

Algernon Pharmaceuticals Hits Co-Primary Endpoint in its

VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT:. ....

United Kingdom , British Columbia , Christopherj Moreau , Martin Kolb , Jacky Smith , Airway Fibrosis , Mcmaster University , International Colloquium On Lung , Honorary Consultant At Manchester University , University Of Manchester , Company Or Algernon , Algernon Pharmaceuticals Inc , Respiratory Medicine , Honorary Consultant , Manchester University , International Colloquium , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals , Chronic Cough , Phase 2 ,